Latest filing published 04 Jun 2024 for XSpray Pharma AK, €13k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ribbskottet AB Anders Bladh: trading record in brief
Ribbskottet AB Anders Bladh discloses dealings in XSpray Pharma AK to Finansinspektionen. We count 3 filings; the first trade dates from 27 May 2024 and the latest from 4 June 2024.
Purchases make up the whole of the open-market record (3 purchases, €103k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €30k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 4 June 2024, the filings show an open-market purchase worth €13k in XSpray Pharma AK. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Ribbskottet AB Anders Bladh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,958 shares@ SEK 74.3912.5% of flowAktieISIN SE0009973563FI:csv-4cd9541ab00591dd56a7Canonical exit: 2 Sept 2024 (T+90)
- 5,000 shares@ SEK 68.5329.1% of flowAktieISIN SE0009973563FI:csv-34f292da246ff566bd57Canonical exit: 29 Aug 2024 (T+90)
- 10,000 shares@ SEK 69.0058.4% of flowAktieISIN SE0009973563FI:csv-a2bfd469e87ad7155081Canonical exit: 25 Aug 2024 (T+90)
3 of 3 declarations